Brokers’ picks: Glenmark, Bajaj Corp

CS Keeps ‘Outperform’ on Glenmark


Glenmark has a strong generic portfolio and maydeliver 23% EPS CAGR over the next 2 yrs.

It is most successful in innovative research from India and has been able to run novel compound research as cash-positive.

It’s been outpacing industry growth due to high exposure to fastest growing molecules &strong execution.

Bajaj Corp Stays a ‘Buy’ PhillipCap

Bajaj Corp (BJCorp) has acquired the personal care brand No Marks which primarily operates in the niche category of Anti Marks.

Phillip Capital view BJCorp’s strategy to inorganically diversify its product mix with foray into the highgrowth high-margin personal category a strategic fit.